Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;19(2):87-88.
doi: 10.31887/DCNS.2017.19.2/fthibaut.

Anxiety disorders: a review of current literature

Florence Thibaut  1
Affiliations
Review

Anxiety disorders: a review of current literature

Florence Thibaut. Dialogues Clin Neurosci. 2017 Jun.

Abstract

Anxiety disorders are the most prevalent psychiatric disorders. There is a high comorbidity between anxiety (especially generalized anxiety disorders or panic disorders) and depressive disorders or between anxiety disorders, which renders treatment more complex. Current guidelines do not recommend benzodiazepines as first-line treatments due to their potential side effects. Selective serotonin reuptake inhibitors and selective serotonin norepinephrine reuptake inhibitors are recommended as first-line treatments. Psychotherapy, in association with pharmacotherapy, is associated with better efficacy. Finally, a bio-psycho-social model is hypothesized in anxiety disorders.

Keywords: anxiety; environmental factor; epidemiology; genetics.

PubMed Disclaimer

References

    1. Thibaut F. The role of sex and gender in neuropsychiatric disorders. Dialogues Clin Neurosci. 2016;18(4):351–352. - PMC - PubMed
    1. Thibaut F. Gender does matter in clinical research. Eur Arch Psychiatry Clin Neurosci. 2017;267(4):283–284. - PubMed
    1. Wittchen HU., Kessler RC., Beesdo K., Krause P., Hofler M., Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63((suppl 8)):24–34. - PubMed
    1. Bandelow B., Baldwin D., Abelli M., et al Biomarkers for anxiety disorders, OCD and PTSD: a consensus statement part II. Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry. 2017;18(3):162–214. - PMC - PubMed
    1. Parsaik AK., Mascarenhas SS., Khosh-Chashm D., et al Mortality associated with anxiolytic and hypnotic drugs. A systematic review and meta-analysis. Aust NZ J Psychiatry. 2016;50(6):520–533. - PubMed

MeSH terms